Undergraduate Student Team Selected for 2013 Zero to 510 Program
A team of undergraduate biomedical engineering students are in the process of developing
a next generation heart device. The students formed the company, Asclepius Innovative Solutions (AIS for short), for developing a leadless partially implantable cardiac defibrillator.
This team was one of six to be selected for the 2013 Zero to 510 program, the nation’s
first, cohort-based medical device accelerator. The Zero to 510 program provides instruction,
mentorship, business planning, milestone making and capital needed to accelerate the
path for launching a medical device.
Carlos Ortiz, President/CEO, AIS Inc.
|Marsalas Whitaker, Co-Founder/Director of Research & Development, AIS Inc.
The AIS implantable cardiac defibrillator, Guardian, is less invasive than current
devices. In addition, the device includes a revolutionary monitoring system. The device
was highlighted in this August 2013 MedCity news article by Deanna Pogorelc, A life-saving heart device with a check-engine light.
Image of the Guardian Implantable Cardiac Defibrillator